Publication | Open Access

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

OncologyMetronomic TherapyPharmacologyAdvanced LiposarcomaEribulin Versus DacarbazinePharmacotherapyCancer TreatmentMedicinePhase 3